Read this company snapshot
Daily valuation snapshot
Ginkgo Bioworks Holdings, Inc.: source evidence dated 2026-10-09.
- Daily close (USD)
- $13
- Market capitalization (USD)
- $828,244,326
- Price / earnings (TTM)
- Not reported
- Price / book
- 1.97
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research DNA in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research DNA in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing DNA with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $13 |
| Market capitalization (USD) | $828,244,326 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.97 |
No matching rows. Clear the filter to see all records.
Read DNA's valuation metrics
Company size
Ginkgo Bioworks Holdings, Inc.'s recorded market capitalization is $828,244,326. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
DNA's recorded price-to-book ratio is 1.97. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Ginkgo Bioworks Holdings, Inc. with Aurora
Use the snapshot above to ask a specific question about DNA. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow DNA's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.